Literature DB >> 10155317

The defined daily dose as a tool in pharmacoeconomics. Advantages and limitations.

K W Clarke1, D Gray.   

Abstract

Mesh:

Year:  1995        PMID: 10155317     DOI: 10.2165/00019053-199507040-00002

Source DB:  PubMed          Journal:  Pharmacoeconomics        ISSN: 1170-7690            Impact factor:   4.981


× No keyword cloud information.
  12 in total

1.  Guidelines for performing a pharmacoeconomic analysis.

Authors:  L M Jolicoeur; A J Jones-Grizzle; J G Boyer
Journal:  Am J Hosp Pharm       Date:  1992-07

2.  Pharmacoeconomic research and clinical trials: concepts and issues.

Authors:  J L Bootman; L N Larson; W F McGhan; R J Townsend
Journal:  DICP       Date:  1989-09

3.  Studies on drug utilization: bilateral case study in Poland and Sweden.

Authors:  T J Szuba; B Westerholm
Journal:  Soc Sci Med       Date:  1989       Impact factor: 4.634

4.  Approaches to assessing the rationality of drug usage in a developed country.

Authors:  G Boëthius
Journal:  Acta Med Scand Suppl       Date:  1988

Review 5.  Epidemiology of drug utilization--basic concepts and methodology.

Authors:  P K Lunde; I Baksaas
Journal:  Acta Med Scand Suppl       Date:  1988

6.  Standardizing methodologies for economic evaluation in health care. Practice, problems, and potential.

Authors:  M Drummond; A Brandt; B Luce; J Rovira
Journal:  Int J Technol Assess Health Care       Date:  1993       Impact factor: 2.188

7.  General practice fundholding: observations on prescribing patterns and costs using the defined daily dose method.

Authors:  M Maxwell; D Heaney; J G Howie; S Noble
Journal:  BMJ       Date:  1993-11-06

8.  Defined daily doses in relation to hypolipidaemic efficacy of lovastatin, pravastatin, and simvastatin.

Authors:  D R Illingworth; D W Erkelens; U Keller; G R Thompson; M J Tikkanen
Journal:  Lancet       Date:  1994-06-18       Impact factor: 79.321

9.  General practitioner prescribing rates and costs.

Authors:  L A Malcolm; C S Higgins
Journal:  N Z Med J       Date:  1981-05-13

10.  Utilization of drug sales data for the epidemiology of chronic diseases: the example of diabetes. The EURODIAB Subarea C Study Group.

Authors:  L Papoz
Journal:  Epidemiology       Date:  1993-09       Impact factor: 4.822

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.